Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phanquinone is a synthetic small molecule belonging to the o‑quinones class, specifically derived by oxidation of 4,7‑phenanthroline. It has been investigated primarily as an antiprotozoal agent and for its bactericidal activity against a wide range of Gram-positive and Gram-negative organisms. Its mechanism of action is not fully elucidated but is thought to involve the generation of reactive oxygen species leading to oxidative stress in target cells. Historically used for amoebic and bacillary dysentery, it has also been explored for broader anti-infective applications[1][2][3][4][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phanquinone.